20.07.2015 Views

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

91MEV007Purification and Characterisation of the Flav<strong>in</strong>-DependentMonodechloroam<strong>in</strong>opyrrolnitr<strong>in</strong> 3-Halogenase fromPyrrolnitr<strong>in</strong> BiosynthesisA. Adam*, K.-H. van PéeTU Dresden, Institut für Biochemie, Dresden, GermanyPyrrolnitr<strong>in</strong> is an antifungal compound first isolated from Pseudomonaspyrroc<strong>in</strong>ia. The gene cluster and the correspond<strong>in</strong>g enzymes responsiblefor pyrrolnitr<strong>in</strong> biosynthesis were identified <strong>in</strong> Pseudomonas fluorescens(BL915) and other pyrrolnitr<strong>in</strong> produc<strong>in</strong>g bacteria. The third enzyme,monodechloroam<strong>in</strong>opyrrolnitr<strong>in</strong> (MCAP) 3-halogenase (PrnC), catalysesthe regioselective chlor<strong>in</strong>ation of MCAP <strong>in</strong> the 3-position of the pyrroler<strong>in</strong>g. PrnC is a flav<strong>in</strong>-dependent halogenase and its reaction mechanism issuggested to be very similar to that of other flav<strong>in</strong>-dependent halogenases.However, the am<strong>in</strong>o acid sequence shows hardly any similarity to theam<strong>in</strong>o acid sequence of tryptophan halogenases for some of which threedimensionalstructures are known.Additionally, PrnC is, besides the tryptophan halogenases, the only knownflav<strong>in</strong>-dependent halogenase that catalyses the halogenation of a freesubstrate. Other known flav<strong>in</strong>-dependent halogenases catalys<strong>in</strong>g thechlor<strong>in</strong>ation of a pyrrole moiety act on a substrate bound to a peptidylcarrier prote<strong>in</strong> mak<strong>in</strong>g elucidation of the 3-D structure of these enzymes,especially <strong>in</strong> the presence of substrate, very difficult. Thus, the 3-Dstructure of PrnC is of high importance to understand how substratespecificity and regioselectivity are regulated <strong>in</strong> flav<strong>in</strong>-dependenthalogenases.So far, purification of PrnC <strong>in</strong> its active form has not been achievedsatisfactorily which is partially due to the <strong>in</strong>compatibility of the tags usedand the high tendency of PrnC to form aggregates with itself and otherprote<strong>in</strong>s. The lack of purified PrnC so far prevented further detailedanalysis of the enzyme. Here we report a novel purification strategylead<strong>in</strong>g to purified, active PrnC. Us<strong>in</strong>g the GST-fusion prote<strong>in</strong> strategy it ispossible to obta<strong>in</strong> homgeneous PrnC from recomb<strong>in</strong>ant Escherichia colicells. The purity level of the eluted fusion prote<strong>in</strong> highly depends on thegrowth temperature of the E. coli stra<strong>in</strong> used for expression. MALDI-TOF-MS analysis revealed that the chaperon<strong>in</strong> GroEL and other prote<strong>in</strong>s are copurifiedby glutathione aff<strong>in</strong>ity chromatography when the growthtemperature is not reduced to 20 °C. Dilution of the crude extract as wellas the addition of Tween-20 has a high impact on the aff<strong>in</strong>ity of the fusionprote<strong>in</strong> to the glutathione column. The addition of detergent does not<strong>in</strong>hibit halogenat<strong>in</strong>g activity, neither that of the fusion prote<strong>in</strong> nor that ofthe purified PrnC after thromb<strong>in</strong> digestion.Furthermore we can now report on first characterisation results giv<strong>in</strong>g firsth<strong>in</strong>ts towards the reaction mechanism of PrnC.van Pée, K. H. and Ligon, J. M., Nat. Prod. Rep., 2000, 17, 157.Hammer, P. E., Hill, D. S., Lam, S. T., van Pée, K. H., Ligon, J. M., Appl. Environ. Microbiol., 1997, 63,2147.Dorreste<strong>in</strong>, P. C., Yeh, E., Garneau-Tsodikova, S., Kelleher, N. L., Walsh, C. T., PNAS, 2005, 39, 13843.MEV008EasG and FgaFS are key enzymes <strong>in</strong> the differentiation ofergot alkaloid biosynthesis <strong>in</strong> Claviceps purpurea andAspergillus fumigatusM. Matuschek* 1 , C. Wallwey 1 , X. Xie 2 , S.-M. Li 11 Philipps-Universität Marburg, Institut für Pharmazeutische Biologie undBiotechnologie, Marburg, Germany2 Philipps-Universität Marburg, Fachbereich Chemie, Marburg, GermanyErgot alkaloids are secondary metabolites belong<strong>in</strong>g to <strong>in</strong>dole derivativesand are produced by a wide range of fungi with Claviceps purpurea as themost important producer for medical use. They show a broad spectrum ofbiological activities and their toxic effects were reported back to themiddle ages. The early steps of ergot alkaloid biosynthesis are shared byC. purpurea and Aspergillus fumigatus, whereas later steps differ <strong>in</strong> thetwo fungi.[1] Chanoclav<strong>in</strong>e-I aldehyde[2] was proposed as branch po<strong>in</strong>tfor the biosynthesis <strong>in</strong> both fungi,[3] which is converted <strong>in</strong> A. fumigatus tothe clav<strong>in</strong>e-type alkaloid festuclav<strong>in</strong>e by the festuclav<strong>in</strong>e synthase FgaFS<strong>in</strong> the presence of the old yellow enzyme FgaOx3.[1] In C. purpureachanoclav<strong>in</strong>e-I aldehyde is converted to agroclav<strong>in</strong>e by EasG <strong>in</strong> thepresence of reduced glutathione without a requirement of EasA.[4] Theenzymes were purified by aff<strong>in</strong>ity chromatography after overproduction <strong>in</strong>E. coli and characterized biochemically. The <strong>in</strong> vitro results for theformation of festuclav<strong>in</strong>e catalysed by FgaOx3 and FgaFS proved tworeduction steps. In contrast, agroclav<strong>in</strong>e differs from festuclav<strong>in</strong>e by adouble bond between C8 and C9. Therefore only one reduction, butadditionally an isomerisation step is necessary. We have shown that EasGwas responsible for the reduction step and a non-enzymatic adduct withreduced glutathione for the isomerisation. The structures of festuclav<strong>in</strong>eand agroclav<strong>in</strong>e were unequivocally elucidated by NMR and MS analyses.In summary, EasG and FgaFS are the key enzymes controll<strong>in</strong>g the branchpo<strong>in</strong>t of ergot alkaloid biosynthesis <strong>in</strong> C. purpurea and A. fumigatus.[1.] C. Wallwey, M. Matuschek, X.-L. Xie, S.-M. Li, Org. Biomol. Chem. 2010, 8, 3500-3508.[2.] C. Wallwey, M. Matuschek, S.-M. Li, Arch. Microbiol. 2010, 192, 127-134.[3.] C. M. Coyle, J. Z. Cheng, S. E. O'Connor, D. G. Panaccione, Appl. Environ. Microbiol. 2010, 76, 3898-3903.[4.] M. Matuschek, C. Wallwey, X. Xie, S. M. Li, Org. Biomol. Chem. 2011, 9, 4328-4335.MEV009Biosynthesis of Cephlaospor<strong>in</strong> C Through Improved stra<strong>in</strong>s ofAspergillus and Acremonium speciesZ.-E. Bilal*, A. YousafInstitute of Agricultural sciences, University of the Punjab, Lahore,Pakistan., Institute of Agricultural sciences, University of the Punjab,Lahore, Pakistan., Lahore, PakistanAntibiotics are secondary metabolites produced by microorganisms,extremely important to the health of our society. Cephalospor<strong>in</strong>s are broadspectrumantibiotics which are very similar <strong>in</strong> structure and action topenicill<strong>in</strong>s but more resistant to -lactamases. Optimization of media isuseful to <strong>in</strong>crease the production of antibiotics. Induction of mutation iscommonly employed to <strong>in</strong>crease the yield of secondary metabolites likeantibiotics. Chemical mutation is preferred method because of the ease <strong>in</strong>handl<strong>in</strong>g and avoid<strong>in</strong>g the hazardous effects of radiations.Monitor<strong>in</strong>g the concentrations of antibiotics and their precursors isrequired for their optimized production. Due to higher concentrations ofprote<strong>in</strong>s and other liquid phases <strong>in</strong> fermented broth aseptic sampl<strong>in</strong>g is adifficult task. Spectrophotometeric analysis can be used for the estimationof the antibiotic produced by microbes. Bioassay analysis can be done toconfirm the antibiotic activity of the antibiotic produced. HPLC is used todifferentiate the specific antibiotic from other secondary metabolites ofmicrobes from the fermented broth.The aim of this research work was to optimize media conditions andimprovement of fungal stra<strong>in</strong>s through chemical mutation for enhancedCephalospor<strong>in</strong> C (CPC) production by Aspergillus and Acremonium species.For media optimization different concentrations of media contents wereanalyzed for <strong>in</strong>creased production. Best results were shown byfermentation media supplemented with sucrose 30mg/ml. While DLmethion<strong>in</strong>eshows optimum yield at 3mg/ml; and fermentation mediasupplemented with ammonium sulphate 7.5mg/ml as nitrogen sources gavemaximum yield.For mutation <strong>in</strong>duction fungal stra<strong>in</strong>s were treated with 400g/ml of Ethylmethane sulfonate (EMS) for 30-80 m<strong>in</strong>utes. It was observed that time ofchemical treatment was <strong>in</strong>versely proportional to the survival of fungalstra<strong>in</strong>s; m<strong>in</strong>imum survival rate was obta<strong>in</strong>ed at treatment of 1 hour.The mutants were then further analyzed for CPC production withoptimized media conditions <strong>in</strong> similar way as done earlier before <strong>in</strong>ductionof mutation. Results obta<strong>in</strong>ed showed that very small <strong>in</strong>crease <strong>in</strong> CPCproduction, <strong>in</strong> few fungal stra<strong>in</strong>s but not <strong>in</strong> all. This might be due to<strong>in</strong>sufficient mutation for target genes (i.e., <strong>in</strong>volved <strong>in</strong> CPC production) <strong>in</strong>rema<strong>in</strong><strong>in</strong>g fungal species.The spectrophotometeric and HPLC analysis of fermented broths wereperformed to analyze CPC yields. Similarities were observed <strong>in</strong> the resultsof both analyses. On spectrophotometeric and HPLC analysis, beforemutation maximum yield of CPC (2.583 and 0. 254mg/ml respectively)was obta<strong>in</strong>ed with Acremonium kiliense FCBP # 162, respectively andafter mutation maximum production of CPC (2.346, 0.24mg/mlrespectively) was achieved with Acremonium furcatum FCBP # 409.The bioassay analysis of the fungal stra<strong>in</strong>s and survivors (mutants) wereperformed to confirm antibacterial activity of CPC. The <strong>in</strong>creasedantibacterial activity was observed for some stra<strong>in</strong>s after mutation, forothers it was decreased and it rema<strong>in</strong>ed constant for rema<strong>in</strong><strong>in</strong>g stra<strong>in</strong>s.MEV010Systems biology of the mar<strong>in</strong>e antibiotic producer PhaeobactergallaeciensisA. Kl<strong>in</strong>gner*, A. Bartsch, J. Becker, C. WittmannInstitut für Bioverfahrenstechnik, TU Braunschweig, Braunschweig, GermanyMar<strong>in</strong>e bacteria ga<strong>in</strong> more <strong>in</strong>terest s<strong>in</strong>ce it is assumed that among thesebacteria is a great potential of secondary metabolites which may be of<strong>in</strong>dustrial or medical <strong>in</strong>terest. The Roseobacter clade is one of the mostprevalent mar<strong>in</strong>e microorganisms, which are highly distributed <strong>in</strong> theoceans [1]. Many new species were found <strong>in</strong> the last few years and a richrepertoire of metabolic pathways has been identified. However, there islittle <strong>in</strong>formation about the <strong>in</strong> vivo use <strong>in</strong> the mar<strong>in</strong>e environment [2, 3].Phaeobacter gallaeciensis has the ability to produce a new <strong>in</strong>terest<strong>in</strong>gantibiotic, the tropoditiethic acid (TDA). Furthermore, other secondarymetabolites, so called “Roseobacticides”, were found, which <strong>in</strong>hibit thegrowth of diverse mar<strong>in</strong>e algae and bacteria [4, 5]. This makes thebacterium <strong>in</strong>terest<strong>in</strong>g for studies <strong>in</strong> systems biology, to developoptimization strategies and enhance the secondary metabolite production.In this work P. gallaeciensisis <strong>in</strong>vestigated by systems wide metabolic fluxanalysis us<strong>in</strong>g 13 C-labell<strong>in</strong>g studies and computational flux modell<strong>in</strong>g withthe software OpenFlux [6]. This provides a first <strong>in</strong>sight <strong>in</strong>to the <strong>in</strong> vivo useof its pathways. The first set of experiments focussed on the impact ofdifferent carbon sources. Together with transcriptome profil<strong>in</strong>g this willBIOspektrum | Tagungsband <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!